Microsoft Corporation - MSF.DE

MSF.DE Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
MSF.DE	-0.4	2.9	2.9	7.9	6.5	14.8	68.8	180.0	931.4	898.4
S&P 500	-0.4	1.6	0.9	4.9	12.3	25.1	38.1	84.9	196.1	34395.9

Compare MSF.DE with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	MSF.DE
name	Microsoft Corporation
price	424.3
changes percentage	-0.4341
change	-1.85
day low	421.1
day high	426.75
year high	435.25
year low	336.4
market cap	3154619584000
price avg 50	412.764
price avg 200	395.898
exchange	XETRA
volume	18603
avg volume	30847
open	426.2
previous close	426.15
eps	11.62
pe	36.51
earnings announcement	2025-01-29T21:00:00.000+0000
shares outstanding	7434880000
timestamp	2025-01-24 16:35:52

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 53.0%

Overall Quarterly Financial Health: 73.7%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000789019
revenue	245122000000	211915000000	15.67
gross profit	171008000000	146052000000	17.09
gross profit ratio	0.7	0.69	1.23
research and development expenses	29510000000	27195000000	8.51
operating expenses	61575000000	57529000000	7.03
interest income	3157000000	2994000000	5.44
interest expense	2935000000	1968000000	49.14
ebitda	131720000000	105140000000	25.28
ebitdaratio	0.54	0.5	8.29
operating income	109433000000	88523000000	23.62
operating income ratio	0.45	0.42	6.87
net income	88136000000	72361000000	21.80
net income ratio	0.36	0.34	5.30
eps	11.86	9.72	22.02

Overall Score of Annual Income Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 245,122 million in 2024 from 211,915 million in 2023 representing a change of 15.67%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 171,008 million in 2024 from 146,052 million in 2023 representing a change of 17.09%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 29,510 million in 2024 from 27,195 million in 2023 representing a change of 8.51%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 131,720 million in 2024 from 105,140 million in 2023 representing a change of 25.28%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Net Income: Net income increased to 88,136 million in 2024 from 72,361 million in 2023 representing a change of 21.8%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 11.86 in 2024 from 11.86 in 2023 representing a change of 22.02%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 61,575 million in 2024 from 57,529 million in 2023 representing a change of 7.03%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Operating Income: Operating income decreased to 109,433 million in 2024 from 88,523 million in 2023 representing a change of 23.62%. The decrease in operating income indicates worse operational performance and decreased profitability.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2025Q1	2024Q4	Q/Q change %
0000789019
revenue	65585000000	64727000000	1.33
gross profit	45486000000	45043000000	0.98
gross profit ratio	0.69	0.7	-0.34
research and development expenses	7544000000	8056000000	-6.36
operating expenses	14934000000	17118000000	-12.76
interest income	681000000	638000000	6.74
interest expense	582000000	701000000	-16.98
ebitda	37935000000	34305000000	10.58
ebitdaratio	0.58	0.53	9.13
operating income	30552000000	27925000000	9.41
operating income ratio	0.47	0.43	7.98
net income	24667000000	22036000000	11.94
net income ratio	0.38	0.34	10.48
eps	3.3	2.96	11.49

Overall Score of Quarterly Income Statement

0.88 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 65,585 million in 2025Q1 from 64,727 million in 2024Q4 representing a change of 1.33%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 45,486 million in 2025Q1 from 45,043 million in 2024Q4 representing a change of 0.98%. This indicates a sales profitability growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to 14,934 million in 2025Q1 from 17,118 million in 2024Q4 representing a change of -12.76%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 37,935 million in 2025Q1 from 34,305 million in 2024Q4 representing a change of 10.58%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 30,552 million in 2025Q1 from 27,925 million in 2024Q4 representing a change of 9.41%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 24,667 million in 2025Q1 from 22,036 million in 2024Q4 representing a change of 11.94%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 3.3 in 2025Q1 from 3.3 in 2024Q4 representing a change of 11.49%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 7,544 million in 2025Q1 from 8,056 million in 2024Q4 representing a change of -6.36%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000789019
total assets	512163000000	411976000000	24.32
total liabilities	243686000000	205753000000	18.44
total equity	268477000000	206223000000	30.19
cash and cash equivalents	18315000000	34704000000	-47.23
short term investments	57216000000	76552000000	-25.26
long term investments	14600000000	9879000000	47.79
total current assets	159734000000	184257000000	-13.31
total non current assets	352429000000	227719000000	54.76
total current liabilities	125286000000	104149000000	20.29
total non current liabilities	118400000000	101604000000	16.53
common stock	100923000000	93718000000	7.69
retained earnings	173144000000	118848000000	45.69
total debt	97852000000	79441000000	23.18

Overall Score of Annual Balance Sheet

0.4 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 512,163 million in 2024 from 411,976 million in 2023 representing a change of 24.32%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 268,477 million in 2024 from 206,223 million in 2023 representing a change of 30.19%. This indicates an increase in shareholders' equity.

  Common Stock: Common Stock increased to 100,923 in 2024 from 93,718 in 2023 representing a change of 7.69%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 173,144 million in 2024 from 118,848 million in 2023 representing a change of 45.69%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 243,686 million in 2024 from 205,753 million in 2023 representing a change of 18.44%. This indicates an increase in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 18,315 million in 2024 from 34,704 million in 2023 representing a change of -47.23%. This indicates a decrease in available liquid assets.

  Short Term Investments: Short Term Investments decreased to 57,216 million in 2024 from 76,552 million in 2023 representing a change of -25.26%. This indicates a decrease in short-term investment holdings.

  Total Current Assets: Total Current Assets decreased to 159,734 million in 2024 from 184,257 million in 2023 representing a change of -13.31%. This indicates a worsen liquidity position.

  Total Current Liabilities: Total Current Liabilities increased to 125,286 million in 2024 from 104,149 million in 2023 representing a change of 20.29%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 97,852 million in 2024 from 79,441 million in 2023 representing a change of 23.18%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2025Q1	2024Q4	Q/Q change %
0000789019
total assets	523013000000	512163000000	2.12
total liabilities	235290000000	243686000000	-3.45
total equity	287723000000	268477000000	7.17
cash and cash equivalents	20840000000	18315000000	13.79
short term investments	57589000000	57216000000	0.65
long term investments	15778000000	14600000000	8.07
total current assets	149926000000	159734000000	-6.14
total non current assets	373087000000	352429000000	5.86
total current liabilities	115200000000	125286000000	-8.05
total non current liabilities	120090000000	118400000000	1.43
common stock	102976000000	100923000000	2.03
retained earnings	188929000000	173144000000	9.12
total debt	61478000000	97852000000	-37.17

Overall Score of Quarterly Balance Sheet

0.9 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 523,013 million in 2025Q1 from 512,163 million in 2024Q4 representing a change of 2.12%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 235,290 million in 2025Q1 from 243,686 million in 2024Q4 representing a change of -3.45%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 287,723 million in 2025Q1 from 268,477 million in 2024Q4 representing a change of 7.17%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 20,840 million in 2025Q1 from 18,315 million in 2024Q4 representing a change of 13.79%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 57,589 million in 2025Q1 from 57,216 million in 2024Q4 representing a change of 0.65%. This indicates an increase in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities decreased to 115,200 million in 2025Q1 from 125,286 million in 2024Q4 representing a change of -8.05%. This indicates a lower short-term debt burden.

  Common Stock: Common Stock increased to 102,976 in 2025Q1 from 100,923 in 2024Q4 representing a change of 2.03%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 188,929 million in 2025Q1 from 173,144 million in 2024Q4 representing a change of 9.12%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 61,478 million in 2025Q1 from 97,852 million in 2024Q4 representing a change of -37.17%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Current Assets: Total Current Assets decreased to 149,926 million in 2025Q1 from 159,734 million in 2024Q4 representing a change of -6.14%. This indicates a worsen liquidity position.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000789019
net change in cash	-16389000000	20773000000	-178.90
operating cash flow	118548000000	87582000000	35.36
free cash flow	74071000000	59475000000	24.54
capital expenditure	-44477000000	-28107000000	-58.24
depreciation and amortization	22287000000	13861000000	60.79
deferred income tax	-4738000000	-6059000000	21.80
stock based compensation	10734000000	9611000000	11.68
accounts payables	3545000000	-2721000000	230.28
inventory	1284000000	1242000000	3.38
acquisitions net	-69132000000	-1670000000	-4039.64
investments in property plant and equipment	-44477000000	-28107000000	-58.24
net cash used for investing activites	-96970000000	-22680000000	-327.56
debt repayment	575000000	-2750000000	120.91
common stock issued	2002000000	1866000000	7.29
common stock repurchased	-17254000000	-22245000000	22.44
dividends paid	-21771000000	-19800000000	-9.95
net cash used provided by financing activities	-37757000000	-43935000000	14.06
cash at end of period	18315000000	34704000000	-47.23
accounts receivables	-7191000000	-4087000000	-75.95
cash at beginning of period	34704000000	13931000000	149.11

Overall Score of Annual Cashflow Statement

0.44 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -16,389 million in 2024 from 20,773 million in 2023 representing a change of -178.9%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Deferred Income Tax: Deferred Income Tax increased to -4,738 million in 2024 from -6,059 million in 2023 representing a change of 21.8%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 10,734 million in 2024 from 9,611 million in 2023 representing a change of 11.68%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables increased to 3,545 million in 2024 from 2,721 million in 2023 representing a change of 230.28%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Dividends Paid: Dividends Paid decreased to -21,771 million in 2024 from -19,800 million in 2023 representing a change of -9.95%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• 📈 Positive Indicators

  Operating Cash Flow: Operating Cash Flow increased to 118,548 million in 2024 from 87,582 million in 2023 representing a change of 35.36%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 74,071 million in 2024 from 59,475 million in 2023 representing a change of 24.54%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -44,477 million in 2024 from -28,107 million in 2023 representing a change of -58.24%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Receivables: Accounts Receivables decreased to -7,191 million in 2024 from -4,087 million in 2023 representing a change of -75.95%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2025Q1	2024Q4	Q/Q change %
0000789019
operating cash flow	34180000000	37195000000	-8.11
free cash flow	19257000000	23322000000	-17.43
capital expenditure	-14923000000	-13873000000	-7.57
depreciation and amortization	7383000000	6380000000	15.72
deferred income tax	-1433000000	-1145000000	-25.15
stock based compensation	2832000000	2696000000	5.04
accounts receivables	14037000000	-13246000000	205.97
accounts payables	-916000000	4204000000	-121.79
inventory	-373000000	55000000	-778.18
acquisitions net	-1849000000	-1342000000	-37.78
investments in property plant and equipment	-14923000000	-13873000000	-7.57
net cash used for investing activites	-15201000000	-14848000000	-2.38
debt repayment	-6712000000	-14010000000	52.09
common stock issued	706000000	534000000	32.21
common stock repurchased	-4107000000	-4210000000	2.45
dividends paid	-5574000000	-5574000000	0.00
net cash used provided by financing activities	-16576000000	-23563000000	29.65
net change in cash	2525000000	-1319000000	291.43
cash at end of period	20840000000	18315000000	13.79
cash at beginning of period	18315000000	19634000000	-6.72

Overall Score of Quarterly Cashflow Statement

0.43 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 2,525 million in 2025Q1 from -1,319 million in 2024Q4 representing a change of 291.43%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure decreased to -14,923 million in 2025Q1 from -13,873 million in 2024Q4 representing a change of -7.57%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Payables: The absolute value of Accounts Payables decreased to 916 million in 2025Q1 from 4,204 million in 2024Q4 representing a change of -121.79%. This indicates that the company has reduced its outstanding obligations to its suppliers.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 34,180 million in 2025Q1 from 37,195 million in 2024Q4 representing a change of -8.11%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 19,257 million in 2025Q1 from 23,322 million in 2024Q4 representing a change of -17.43%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Stock-Based Compensation: Stock-Based Compensation increased to 2,832 million in 2025Q1 from 2,696 million in 2024Q4 representing a change of 5.04%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Receivables: Accounts Receivables increased to 14,037 in 2025Q1 from -13,246 million in 2024Q4 representing a change of 205.97%. This suggests that the company is less capable of collecting payments from its customers.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q1 2025 Earnings call transcript
Q4 2024 Earnings call transcript
Q3 2024 Earnings call transcript
Q2 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript
Q2 2023 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2024-06-30	2023-06-30	Y/Y change %
FY
calendar year	2024	2023	NaN
revenue per share	32.99	28.46	15.90
net income per share	11.86	9.72	22.05
operating cash flow per share	15.95	11.76	35.63
free cash flow per share	9.97	7.99	24.79
cash per share	10.16	14.94	-31.97
book value per share	36.13	27.7	30.45
tangible book value per share	16.37	17.32	-5.48
shareholders equity per share	36.13	27.7	30.45
interest debt per share	13.56	10.93	24.05
market cap	3393960630000	2535660840000	33.85
enterprise value	3473497630000	2580397840000	34.61
pe ratio	38.51	35.04	9.89
price to sales ratio	13.85	11.97	15.72
pocfratio	28.63	28.95	-1.11
pfcf ratio	45.82	42.63	7.47
pb ratio	12.64	12.3	2.81
ptb ratio	12.64	12.3	2.81
ev to sales	14.17	12.18	16.38
enterprise value over ebitda	26.11	24.54	6.41
ev to operating cash flow	29.3	29.46	-0.55
ev to free cash flow	46.89	43.39	8.09
earnings yield	0.03	0.03	-9.00
free cash flow yield	0.02	0.02	-6.95
debt to equity	0.36	0.39	-5.39
debt to assets	0.19	0.19	-0.92
net debt to ebitda	0.6	0.43	40.54
current ratio	1.27	1.77	-27.93
interest coverage	37.29	44.98	-17.11
income quality	1.35	1.21	11.13
dividend yield	0.01	0.01	-17.85
payout ratio	0.25	0.27	-9.73
sales general and administrative to revenue	0.03	0.04	-13.16
research and ddevelopement to revenue	0.12	0.13	-6.19
intangibles to total assets	0.29	0.19	52.87
capex to operating cash flow	0.38	0.32	16.91
capex to revenue	0.18	0.13	36.80
capex to depreciation	2.0	2.03	-1.58
stock based compensation to revenue	0.04	0.05	-3.45
graham number	98.19	77.82	26.18
roic	0.22	0.23	-1.66
return on tangible assets	0.24	0.22	11.59
graham net net	-16.8	-7.62	-120.50
working capital	34448000000	80108000000	-57.00
tangible asset value	121660000000	128971000000	-5.67
net current asset value	-83952000000	-21496000000	-290.55
invested capital	335817000000	267347000000	25.61
average receivables	52806000000	46474500000	13.62
average payables	20045500000	18547500000	8.08
average inventory	1873000000	3121000000	-39.99
days sales outstanding	84.76	83.86	1.08
days payables outstanding	108.33	100.28	8.03
days of inventory on hand	6.14	13.85	-55.71
receivables turnover	4.31	4.35	-1.07
payables turnover	3.37	3.64	-7.43
inventory turnover	59.48	26.35	125.78
roe	0.33	0.35	-6.44
capex per share	5.99	3.77	58.56

• Neutral

  ROE: Return on Equity (ROE) decreased to 0.33 on 2024-06-30 from 0.35 on 2023-06-30, representing a change of -6.44%. However, ROE is >= 15%, suggesting that the company has been generating high returns for its shareholders still.

  Current Ratio: Current Ratio decreased to 1.27 on 2024-06-30 from 1.77 on 2023-06-30, representing a change of -27.93%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 38.51 on 2024-06-30 from 35.04 on 2023-06-30, representing a change of 9.89%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.36 on 2024-06-30 from 0.39 on 2023-06-30, representing a change of -5.39%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-09-30 Q1	2024-06-30 Q4	Q/Q change %
MSF.DE
calendar year	2025	2024	NaN
revenue per share	8.82	8.71	1.33
net income per share	3.32	2.96	11.94
operating cash flow per share	4.6	5.0	-8.11
free cash flow per share	2.59	3.14	-17.43
cash per share	10.55	10.16	3.84
book value per share	38.71	36.12	7.17
tangible book value per share	19.05	16.37	16.39
shareholders equity per share	38.71	36.12	7.17
interest debt per share	13.11	13.26	-1.15
market cap	3198419900000	3394874090000	-5.79
enterprise value	3274417900000	3474411090000	-5.76
pe ratio	32.42	38.52	-15.84
price to sales ratio	48.77	52.45	-7.02
pocfratio	93.58	91.27	2.52
pfcf ratio	166.09	145.57	14.10
pb ratio	11.12	12.64	-12.09
ptb ratio	11.12	12.64	-12.09
ev to sales	49.93	53.68	-6.99
enterprise value over ebitda	85.64	101.28	-15.44
ev to operating cash flow	95.8	93.41	2.56
ev to free cash flow	170.04	148.98	14.14
earnings yield	0.01	0.01	18.82
free cash flow yield	0.01	0.01	-12.36
debt to equity	0.34	0.36	-7.66
debt to assets	0.19	0.19	-3.09
net debt to ebitda	1.99	2.32	-14.27
current ratio	1.3	1.27	2.08
interest coverage	52.49	39.84	31.78
income quality	1.39	1.69	-17.91
dividend yield	0.0	0.0	6.14
payout ratio	0.23	0.25	-10.67
sales general and administrative to revenue	0.03	0.03	-26.49
research and ddevelopement to revenue	0.12	0.12	-7.58
intangibles to total assets	0.28	0.29	-2.54
capex to operating cash flow	0.44	0.37	17.06
capex to revenue	0.23	0.21	6.16
capex to depreciation	2.02	2.17	-7.04
stock based compensation to revenue	0.04	0.04	3.67
graham number	53.76	49.08	9.53
roic	0.06	0.06	7.66
return on tangible assets	0.07	0.06	8.51
graham net net	-16.54	-16.8	1.52
working capital	34726000000	34448000000	0.81
tangible asset value	141598000000	121660000000	16.39
net current asset value	-85364000000	-83952000000	-1.68
invested capital	354242000000	335817000000	5.49
average receivables	50536000000	50476500000	0.12
average payables	22382000000	20041500000	11.68
average inventory	1436000000	1275000000	12.63
days sales outstanding	60.58	79.15	-23.46
days payables outstanding	101.95	100.57	1.37
days of inventory on hand	7.28	5.7	27.80
receivables turnover	1.49	1.14	30.65
payables turnover	0.88	0.89	-1.35
inventory turnover	12.36	15.8	-21.75
roe	0.09	0.08	4.45
capex per share	2.01	1.87	7.57

• ROE:

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 32.42 on 2024-09-30 Q1 from 38.52 on 2024-06-30 Q4, representing a change of -15.84%. Indicating a decrease in the relative valuation of the company's stock.

• Positive

  Current Ratio: Current Ratio increased to 1.30 on 2024-09-30 Q1 from 1.27 on 2024-06-30 Q4, representing a change of 2.08%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.34 on 2024-09-30 Q1 from 0.36 on 2024-06-30 Q4, representing a change of -7.66%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is 245.85 which is lower than current price 424.3, indicates the company may be overvalued.